Potassium homeostasis and therapeutic intervention with sodium zirconium cyclosilicate: A model‐informed drug development case study
Abstract Potassium (K+) is the main intracellular cation in the body. Elevated K+ levels (hyperkalemia) increase the risk of life‐threatening arrhythmias and sudden cardiac death. However, the details of K+ homeostasis and the effects of orally administered K+ binders, such as sodium zirconium cyclo...
Saved in:
Main Authors: | Lindsay E. Clegg (Author), Lulu Chu (Author), Mats Nagard (Author), David W. Boulton (Author), Robert C. Penland (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Letter to the editor regarding ''Patiromer and Sodium Zirconium Cyclosilicate in Treatment of Hyperkalemia: A Systematic Review and Meta-analysis: Patiromer and Sodium Zirconium Cyclosilicate in Hyperkalemia'
by: Donna Zarzuela, PharmD, et al.
Published: (2021) -
Sodium zirconium cyclosilicate (ZS-9) treatment in patients with serum potassium >6.5 mEq/L
by: Henrik Rasmussen
Published: (2015) -
Cost-effectiveness analysis of sodium zirconium cyclosilicate for treating hyperkalemia among Chinese patients
by: Lei Tian, et al.
Published: (2023) -
Patiromer and Sodium Zirconium Cyclosilicate in Treatment of Hyperkalemia: A Systematic Review and Meta-Analysis
by: Dhan Bahadur Shrestha, MD Resident Physician, et al.
Published: (2021) -
Effects of Patiromer and Sodium Zirconium Cyclosilicate on Blood Pressure in Rats with Chronic Kidney Disease
by: Lingyun Li MD, PhD, et al.
Published: (2024)